Put companies on watchlist
Abbott Laboratories
ISIN: US0028241000
WKN: 850103
Curious about what AI knows about Abbott Laboratories? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Abbott Laboratories · ISIN: US0028241000 · PR Newswire (ID: 20241213CG79084)
13 December 2024 04:58PM

Abbott Increases Quarterly Dividend for 53rd Consecutive Year


  • Dividend increased by 7.3%
  • Quarterly dividend payout has increased more than 60% since 2020
  • 404th consecutive quarterly dividend to be paid by Abbott since 1924

ABBOTT PARK, Ill., Dec. 13, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 59 cents per share, an increase of 7.3%. The company's quarterly dividend payout has increased more than 60% since 2020.

This marks Abbott's 53rd consecutive year of dividend growth. It will be the 404th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Feb. 14, 2025, to shareholders of record at the close of business on Jan. 15, 2025.

Abbott is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott:

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com and on LinkedInFacebookInstagramX and YouTube.

 

Cision View original content:https://www.prnewswire.com/news-releases/abbott-increases-quarterly-dividend-for-53rd-consecutive-year-302331449.html

SOURCE Abbott

Visual performance / price development - Abbott Laboratories
Smart analysis and research tools can be found here.
MIC: XNYS
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942